GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hipromine SA (WAR:HPM) » Definitions » Capex-to-Revenue

Hipromine (WAR:HPM) Capex-to-Revenue : 67.48 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Hipromine Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Hipromine's Capital Expenditure for the three months ended in Mar. 2024 was zł-17.28 Mil. Its Revenue for the three months ended in Mar. 2024 was zł0.26 Mil.

Hence, Hipromine's Capex-to-Revenue for the three months ended in Mar. 2024 was 67.48.


Hipromine Capex-to-Revenue Historical Data

The historical data trend for Hipromine's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hipromine Capex-to-Revenue Chart

Hipromine Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
1.48 3.90 13.63 64.61

Hipromine Quarterly Data
Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.03 4,853.76 58.57 132.06 67.48

Competitive Comparison of Hipromine's Capex-to-Revenue

For the Packaged Foods subindustry, Hipromine's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hipromine's Capex-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hipromine's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hipromine's Capex-to-Revenue falls into.



Hipromine Capex-to-Revenue Calculation

Hipromine's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-131.286) / 2.032
=64.61

Hipromine's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-17.275) / 0.256
=67.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hipromine  (WAR:HPM) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Hipromine Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hipromine's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hipromine (WAR:HPM) Business Description

Traded in Other Exchanges
N/A
Address
ul. Pozna?ska, 12th Floor, Robakowo, POL, 62-023
Hipromine SA is a European scale supplier of an alternative protein produced through innovative, proprietary technology of industrial insect breeding. The company's offer is directed mainly to the market of pet food and fodder for fish farming, as well as livestock and horticulture.

Hipromine (WAR:HPM) Headlines

No Headlines